http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0025766-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-785
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-785
filingDate 1980-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23679847f9d3262124f17e336a886e5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2622549ecb798647c5d3dffd40225d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90e002af93d40263cccbc5ad2bd19354
publicationDate 1981-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0025766-A2
titleOfInvention Pharmaceutical composition comprising modified polyriboinosinic-polyribocytidylic acid, for induction of interferon in primates
abstract A complex of polyriboinosinic-polyribocytidylic acid (poly I:C) with poly-L-lysine hydrobromide ([Iysine.HBr] n ) having a defined molecular weight is prepared which is about 5-15 times as resistant to hydrolysis by pancreatic ribonuclease as the parent poly I:C. A pharmaceutical solution, containing a relatively high concentration of the complex, prepared as described, induces significant antiviral levels of serum interferon in monkeys under conditions in which poly I:C itself induces little or no interferon. An important feature of this invention is that the product is a soluble material requiring no special solubilizing agent, thereby facilitating the preparation of solutions having the desired concentration. The product will hereinafter be designated as poly I:C/poly-L-lysine.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6545138-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5624912-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8303965-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8303966-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5977083-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2207138-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2207138-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2207432-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2617403-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2617486-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7838017-B2
priorityDate 1979-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4024222-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588588
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9544
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485577
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69568
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556976
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450822742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5962
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448008838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56843351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID866

Total number of triples: 47.